Home Medicine Molecular mechanism and intervention measures of microvascular complications in diabetes
Article Open Access

Molecular mechanism and intervention measures of microvascular complications in diabetes

  • Rui Xu , Ziming Fang , Hongyu Wang , Ye Gu , Liying Yu , Boyang Zhang and Jingyu Xu EMAIL logo
Published/Copyright: April 17, 2024
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 19 Issue 1

Abstract

Objective

In this article, the epidemiology, molecular mechanism of occurrence and development, risk factors, and treatment of diabetic microvascular complications such as diabetic nephropathy, diabetic retinopathy, and diabetic peripheral neuropathy were discussed, providing the theoretical basis for more accurate elucidation of the pathogenesis and treatment of diabetic microvascular complications.

Methods

The electronic database of PubMed was searched, and retrieved papers were screened for eligibility by two independent reviewers. Data were extracted using a standardized data extraction form and the quality of included papers was assessed.

Results

Thirty-eight articles were included. Diabetes nephropathy, diabetes peripheral neuropathy, and diabetes retinopathy are the most common and serious microvascular complications of diabetes in clinical patients. Renin–angiotensin system blockers, beta drugs, statins, antivascular endothelial growth factor drugs, and antioxidants can inhibit the occurrence of microvascular complications in diabetes.

Conclusions

However, there has been no breakthrough in the treatment of diabetic microvascular complications. Therefore, prevention of diabetic microvascular complications is more important than treatment.

Keywords: microvascular complication; epidemiology; molecular mechanism; risk factors; treatment

1 Introduction

Diabetes is a global health problem that affects people of all ages. With the change in production and lifestyle, the change in diet structure, and the intensification of population aging, the incidence rate, disability rate, and fatality rate of diabetes have increased year by year [1,2]. Diabetes, hypertension, and malignant tumors have been listed as the main diseases threatening human health and survival. The main clinical manifestations of diabetes patients are hyperglycemia, accompanied by polydipsia, polyphagia, polyuria, and body wasting [3,4]. Patients with diabetes are divided into type I diabetes and type II diabetes according to different states of insulin secretion insufficiency or insulin resistance [4].

Diabetes patients mainly show abnormal metabolism of sugars, lipids, and proteins, which belongs to the category of metabolic syndrome. The main harm of diabetes comes from chronic complications, microvascular complications include diabetic retinopathy (DR), diabetic nephropathy (DN), and diabetic peripheral neuropathy (DPN) [4,5,6]. DPN is a major cause of blindness, hemodialysis, and amputation, so the control of diabetic microvascular complications is the key to diabetes treatment [6]. This article reviews the epidemiology, molecular mechanism of occurrence and development, risk factors, and treatment methods of microvascular complications in diabetes, which provides a theoretical basis for more accurate elucidation of the pathogenesis and treatment of microvascular complications in diabetes.

2 Methods

A literature review was conducted in the PubMed database limited to English-language articles published using the terms: microvascular complication, epidemiology, molecular mechanism, risk factors, and treatment. Articles from 2019 through 2023 regarding pathogenesis and treatment of microvascular complications in diabetes were selected, reviewed, and summarized in this article with a focus on articles published within the previous 3 years. References from each article were also reviewed for additional relevant articles. The inclusion criteria are published peer-reviewed studies: quantitative (experimental and observational) or mixed method research design. The search results were imported into Endnote x7 and duplicates were removed. Two evaluators independently selected titles and abstracts using Rayyan. Publications identified by at least one reviewer as potentially relevant are searched in full-text form, and their qualifications are evaluated by two independent reviewers. When there are disagreements, a third reviewer can be arranged. Manually screen the list of references included in the publication to determine other publications that meet the inclusion criteria.

3 Results

3.1 Epidemiologic

3.1.1 DR

DR is the most common diabetic microvascular complication and the first blinding eye disease in the working population [6,7]. The prevalence varies in different study populations: background stage DR is common in patients with diabetes who have had the disease for 20 years, proliferative diabetic retinopathy (PDR) occurs in about 70% of patients with type 1 diabetes mellitus (T1DM) after 30 years of disease [7,8]. The study found that among patients who developed diabetes before the age of 30 and were treated with insulin, the prevalence of DR Was 71%, the cumulative 4-year prevalence was 59%, and 11% of patients progressed to PDR [8,9]. Among patients who developed diabetes after age 30 and did not use insulin, the prevalence of DR Was 39%, the cumulative 4-year prevalence was 34%, and the progression to PDR was 3% [10].

3.1.2 DN

DN is one of the most serious diabetic microvascular complications and the primary cause of end-stage renal disease (ESRD). The 2007 National Kidney Foundation clinical practice guidelines for chronic kidney disease, NKF-KDOQI proposes to use the name “diabetic kidney disease (DKD)” instead of “diabetic kidney disease” in clinical practice [11,12]. DKD usually presents as an increase in microalbuminuria in the urine, which then progresses to macroalbuminuria and renal failure. British prospective diabetes study (United Kingdom prospective diabetes study and UKPDS) is displayed in the 10 years of duration of diabetes patients in about 25% of the Ⅱ diabetes type 2 diabetes mellitus. Patients with T2DM develop microalbuminuria or more severe DKD [10,11,12,13]. It is estimated that approximately 50% of patients develop the microalbuminuria stage within 19 years of diagnosis of diabetes, and 2–3% of patients progress to the next severe stage each year [13,14].

3.1.3 DPN

DPN is the most common and difficult complication to diagnose and manage. Its clinical manifestations are varied and can involve the body and autonomic nervous system [14]. Due to the existence of different evaluation methods and criteria, the prevalence of DPN varies greatly among different studies. In the European T1DM Complications study, 28% of T1DM patients had DPN [14,15]. A similar incidence was reported in T1DM or T2DM, with a prevalence of 32.3%. Pittsburgh Epidemunidogy of diabetes complications study, Pittsburgh Epidemunidogy of Diabetes Complications Study, PEDC, and the diabetes control and Complications Trial (DCCT) used the same criteria and had a higher prevalence [15]. In the Seattle Prospective Study of Diabetic Foot Disease, 50% of participants were found to have peripheral sensory nerve damage at baseline. The prevalence of diabetic neuropathy in multi-center outpatient clinics in China was 17.2% [16].

The prevalence of diabetic microvascular complications varies among different study populations. After 30 years of age, the prevalence of DR is 20–40%, and the prevalence of PDR is 5–10%. The prevalence of DKD ranges from 20 to 40%, with 2–3% of patients progressing to the next stage of severity each year [15,16,17].

3.2 Molecular mechanism

3.2.1 DR

DR has become an important factor affecting patients’ quality of life. At present, retinopathy has been systematically studied and the molecular mechanism of its pathogenesis has been analyzed [16,17]. In the study of the protective effect of Purendan ultramicro powder on retinopathy of STZ-induced glycosuria rats and its effect on the NF-κB signaling pathway, it was found that PRD may have a protective effect on the retina of diabetic rats by specifically blocking the AGEs/RAGE/NF-κB signaling pathway [17,18]. Previous studies have also confirmed that the Shuangdan Mingmu capsule can play a role in the treatment of DR By regulating the Ras-Raf-1-MEK-ERK pathway, and CTGF can also effectively delay the process of retinal fibrosis through exogenous regulation and the balance between the level of vascular growth factor [14,16,17]. The study found that lowering TLR4 levels may improve obesity and insulin resistance in patients with type 2 diabetes, and targeted inhibition of TLR4 may be a potential target for the treatment of type 2 diabetes and its chronic complications [17,18,19]. Based on the analysis of PD1/PDL1 signaling pathways in the Damien treatment proliferation stage of DR study confirmed that the mechanism of Damien drinks Chinese traditional medicine preparation can improve the proliferation period diabetes complications in patients with retinal visual acuity level, and the process may be through inhibiting patient PD1/PDL1 signal transduction protein expression and activation to restore the function of mononuclear cells, The monocytes are transformed to inhibit inflammation and inhibit the expression of related inflammatory factors [18,19]. In the study of the protective effect and mechanism of silencing information regulatory factor associated enzyme 1 (SIRT1) regulating p38MARK signaling pathway on retinal ganglion cells in DR rats, it was also found that in DR models, SIRT1 expression was up-regulated and inhibited the apoptosis of RGCs [19]. The anti-apoptotic mechanism of RGCs in DR may be related to its inhibition of p38MARK expression.

Although the molecular mechanism of DR has been extensively studied, the root cause of DR has not been fully elucidated. DR is the main cause of clinical blindness in diabetic patients, and early intervention is particularly important for the development of retinopathy and the reduction of the blinding rate [18,19,20].

3.2.2 DN

DN has become the most common cause of ESRD. With the increasing incidence of diabetes, the number of DN patients has shown an obvious upward trend [15,16,17,19]. According to the different responses to insulin, diabetes can be divided into type I diabetes and type II diabetes: the proportion of type I diabetes complicated with DN is about 35%, while the proportion of type II diabetes complicated with DN is about 22% [18,19]. In the study of regulating the renal inflammation in rats with DN through the TLR4/NF-κB signaling pathway, it was found that polydatin has an obvious protective effect on the renal inflammation caused by DN. The mechanism of action may be related to regulating the TLR4/NF-κB signaling pathway and reducing the content of inflammatory factors in kidney tissue [16,17,18,20]. And play anti-inflammatory and protective effects. In the study analyzing the effects of combined treatment of sagliptin on inflammatory factors and mononuclear cell PI3K-Akt pathway in elderly DN patients, it was also confirmed that the treatment of sagliptin can significantly reduce Hb A1c, 24 h UPro, and Cr in elderly DN patients, thus improving renal function [18,19]. At the same time, it can reduce TNF-α, IL-6, and IL-1 in peripheral blood, relieve peripheral inflammatory immune response, and significantly upregulate the phosphorylation levels of PI3K and Akt in peripheral blood mononuclear cells. When improving peripheral blood hyperglycemia, xagliptin can further restore the phosphorylation and activation levels of PI3K/Akt and participate in inhibiting inflammatory reactions [6,7,8,18]. Some scholars have also confirmed that the activation of the TGF/(Smad) signaling pathway and p38MARK signaling pathway in DN patients may be one of the main causes of kidney inflammation, and the elevated level of urine (1-MG protein) is a direct manifestation of impaired glomerular function, and the above indicators can be used as monitoring indicators for severe microangiopathy in diabetic patients [17,18,19]. In the study of regulating the renal inflammation in diabetic DN rats through the TLR4/NF-κB signaling pathway, it was also found that polydatin has a significant protective effect on the renal inflammation caused by DN, and its related mechanism may be related to regulating the TLR4/NF-κB signaling pathway and reducing the content of inflammatory factors in renal tissue [19,20]. And play an anti-inflammatory and protective role. Previous studies have also found that AQP5 may participate in the pathogenesis, development, and deterioration of DN, and the AC–cAMP–PKA pathway has a significant negative regulatory effect on the regulation of aquaporin 5 in renal tissue [20,21]. Previous studies have also confirmed that rhein can improve insulin resistance and inhibit mesangial cell apoptosis by regulating the expression of p-JNK and PPAR, thus protecting the kidney. Moreover, the classical signal transduction pathway mediated by IL-6 through IL-6 binding receptor protein and the transitional transduction pathway mediated by IL-6 through soluble IL-6 receptor have been shown to participate in the pathogenesis of DN [19,20,21].

The pathogenesis of DN may be related to a variety of intracellular signaling pathways, and a signaling pathway may be involved in the regulation of one or several action targets. Therefore, multi-signaling pathways should be analyzed in vivo and in vitro to provide a reference for further elucidating the pathogenesis of DN [21].

3.2.3 DPN–diabetic foot

Diabetic foot is a kind of lower extremity infection ulceration and deep tissue destruction caused by diabetic patients complicated with nerve disease and various degrees of peripheral vascular lesions. Diabetic foot is a systemic disease with surgical symptoms such as extremity ulceration and bacterial infection, as well as clinical manifestations of medical diseases [21]. Diabetic foot is a serious stage in the development of diabetes, which seriously threatens the health of patients, and is also one of the main causes of disability and death of patients [21,22].

The treatment of diabetic feet is usually treated with ulcer therapy, infection therapy, and Charcot joint therapy, but the results are usually not satisfactory [22]. Therefore, the analysis of the molecular mechanism of the onset of diabetic foot has important practical significance for early prevention and treatment. Previous studies have also confirmed that the downregulation of Wnt/β-catenin pathway may lead to pathologic refractory ulcers in diabetic patients, and Simiayongan Decoction can also promote the healing effect of diabetic ulcers (such as diabetic foot) by regulating the level of Wnt/β-catenin signal transduction pathway related protein molecules [21,22,23]. In addition, MEBT/MEBO may dynamically regulate the expression levels of vascular conversion factor β1 and P-smad3 protein molecules, to promote the healing effect of diabetic foot ulcers in diabetic patients. In the study of the effect of peripheral blood mesenchymal stem cell transplantation on angiogenesis phosphatidylinoinositide 3-kinase (key molecule of PI3K signaling pathway)/protein kinase B signaling pathway in diabetic foot rats, it was found that peripheral blood mesenchymal stem cell transplantation can promote the proliferation and differentiation of endothelial cells by regulating the PI3K-AKT signaling pathway [22,23,24]. It can promote the formation of neovascularization in diabetic foot rats. In the analysis of the effects of peripheral blood mesenchymal stem cell transplantation on the angiogenic HIF-1/vascular endothelial growth factor (VEGF) pathway and miR-210 expression in diabetic foot rats, it was also found that peripheral blood mesenchymal stem cell transplantation may promote the proliferation and differentiation of endothelial cells and promote the formation of neovascularization by regulating the HIF-1/VEGF pathway and miR-210 expression [23,24,25]. The analysis of changes in the expression of the Wnt/β-catenin signaling pathway in diabetic ulcers also confirmed that the downregulation of the Wnt/β-catenin pathway may lead to the refractory diabetic ulcers, and the downregulation of this pathway may be derived from the decreased expression of Rspo-3 protein [17,18,24,25].

Diabetic foot is the most common microvascular disease of diabetes, but the current treatment measures are not satisfactory. Therefore, it is necessary to constantly explore the pathogenesis of diabetic foot and actively control the related pathogenesis factors and molecular mechanisms, so as to give priority to prevention and fundamentally reduce the risk of diabetic foot [26].

3.3 Risk factors and interventions

3.3.1 Hyperglycemia

Hyperglycemia is the most important risk factor for the development of diabetic microvascular complications. The DCCT study found that in T1DM patients aged 13–39 years with a disease course of 1–15 years, intensive insulin therapy can effectively delay the appearance and progression of DR [26,27]. For patients without DR at baseline, the intensive treatment group reduced the risk of developing DR by 76% compared with the usual treatment group. For those with mild DR at baseline, the intensive treatment group had a 47% lower risk of DR progressing to PDR or severe NPDR compared to the usual treatment group [25,26,27]. The DCCT study also showed that intensive blood glucose control reduced the prevalence of microalbuminuria by 29% after the first year of treatment. In the secondary prevention cohort, intensive treatment reduced the risk of microalbuminuria progression by 43% and clinical albuminuria progression by 56% [26,27,28]. This effect of enhanced glycemic control was still seen at 4 and 7–8 years of follow-up. The study found that further control of HBA1c to 6.5% still reduced the risk of worsening kidney disease by 21%. Similarly, intensive treatment at 5-year follow-up reduced the development of clinical neuropathy by 64%, abnormal nerve conduction, and abnormal autonomic nervous system function changes by 44 and 53% compared with conventional treatment [27,28]. The SHDCS study in the Chinese population found that patients with HBA1c >7.5% had a 1.52-fold increased risk of microalbuminuria compared with patients with HBA1c <7.5%. However, the study did not find an effect of HBA1c on renal insufficiency in diabetic patients [20,28,29].

3.3.2 Duration of diabetes

The course of diabetes is the main risk factor for microvascular complications of diabetes. The PEDC study evaluated 657 T1DM patients with childhood onset (0–17 years) and found that nearly all patients with diabetes >14 years, of course, developed background stage DR [17,18,19,29]. Among those with diabetes more than 25 years old, three-quarters of those with DR aged 18–29 years and more than half of those over 30 years old had PDR. The prevalence of PDR in the Wisconsin Epidemiological Study of Diabetic Retinopathy increased gradually with the duration of the disease (<5 years for diabetes, no PDR, 15% for 15 years for diabetes, and 67% for 35 years for diabetes) [27,28,29]. The SHDCS study showed that for every 5-year increase in the duration of diabetes, the risk of developing DR Increased by 1.2 times. Similarly, the UKPDS study found that the occurrence and progression of DKD were also related to the course of the disease: the proportion of annual progression from microalbuminuria was 2%, the proportion of progression from microalbuminuria to macroalbuminuria was 2.8%, and the proportion of progression from macroalbuminuria to elevated serum creatinine and renal replacement therapy was 2.3%; The proportion of patients with microalbuminuria for 10 years was 24.9% [14,15,16,17,29,30]. The proportion of patients with macroproteinuria was 5.3 and 0.8% on elevated serum creatinine and renal replacement therapy. There was a similar correlation between DPN and diabetes course. It was found that the frequency of subtypes of different types of neuropathy increased with the increase of time during 5–10 years [16,17,18,19,31]. Some scholars have also reported an increase in diabetic neuropathy with the increase in the course of the disease. The prevalence of diabetic neuropathy was 8.3% at baseline and increased to 41.9% after 10 years [31,32].

3.3.3 Age of onset of diabetes

The age of onset of diabetes is another important risk factor for diabetic microvascular complications. Studies have shown a significant increase in diabetic microvascular complications, including DR, in puberty-onset diabetes patients with a 20-year course of disease compared with prepuberty-onset diabetes [30,31,32]. This change may be related to changes in hormone levels during puberty. The prepubertal course of diabetes was found to contribute little to DR. Although the prevalence of diabetes is higher in relatively older people, the prevalence of DR, especially in PDR, is low in people over 70 years of age when diabetes develops [17,18,29]. Similar to DR, the prevalence of overt DKD is significantly higher in adolescence-diagnosed diabetes than in preadolescence-diagnosed diabetes, and the risk of DKD is associated with the course of the disease after adolescence. Some scholars have found that the prevalence of microalbuminuria in T1DM increases significantly in the stage after adolescence [4,5,30].

Among the above risk factors, the course of diabetes and age of onset belong to uncontrollable risk factors. However, hyperglycemia, hypertension, smoking, and dyslipidemia are controllable risk factors, which can be controlled by intervention measures [28,29,30,32]. However, some patients continue to progress even after controlling risk factors. Therefore, to reveal the complexity of the pathogenesis of diabetic microvascular complications, genetic factors may also play an important role. In addition, the discovery of effective treatment is also an inevitable choice to inhibit its progress [29,30,31,32].

3.4 Treatment

Hyperglycotoxicity results in enhanced polyol pathway activity increased non-enzymatic glycosylation endproducts (AGEs) and protein kinase c. Increased activity of PKC and increased amino-hexose pathway were associated with diabetic complications [12,13,14,33]. Among them, high sugar induced the increase of mitochondrial reactive oxygen species in target cells, which was the initiating factor of the above four pathways. In addition to high glucose toxicity, diabetic hemodynamic abnormalities promote the occurrence and development of diabetic microvascular complications. Activation of the local renin–angiotensin system (RAS) plays an important role in the pathogenesis of diabetic microvascular complications [33,34].

Based on the above research results on the pathogenesis of diabetic microvascular complications, intervention is carried out targeting several molecular targets. It was found that RAS blockers, fibrates, statins, anti-VEGF drugs, and antioxidants can inhibit the development of diabetic microvascular complications [8,9,10,11,34].

3.4.1 RAS blockers

RAS blockers include angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The two drugs have been widely used in the clinical treatment of DKD, which can alleviate proteinuria, protect renal function, and inhibit the progression of DKD [34,35]. Concerning DR treatment, lisinopril has been found to inhibit the progression of DR in T1DM patients with normal blood pressure, with a rate of inhibition of primary progression up to 50% [16,17,35]. Recently, the study results of the DR candesartan trial have aroused concern that ARB Candesartan can reduce the incidence of retinopathy ≥grade 2 in T1DM patients by 18%. The incidence of retinopathy ≥grade 3 was reduced by 35% [33,34,35]. For T2DM patients, Candesartan resulted in a relative 13% reduction in the progression of retinopathy (primary outcome), although this result was not statistically significant; it resulted in a significant 34% increase in patients with improved retinopathy (secondary outcome) [35,36].

Alicylen is a representative renin inhibitor, and its application in diabetes has been in the clinical application research stage, mainly focusing on the protective effect on DN, diabetes complicated with hypertension, and target organs. It provides a new way for the adjuvant treatment of diabetes, but the long-term efficacy of the application in diabetic patients still needs to be explored in large-scale clinical trials [34,35,36].

3.4.2 Fibrates

Peroxisouce proliferator-activated receptor-α (PPAR-α) is a member of the receptor superfamily and is involved in lipid metabolism and glucose homeostasis after activation by membrane ligands [36]. As an agonist of PPAR-α, fenofibrate has been widely recognized for its lipid-regulating effects and inhibition of the development of atherosclerosis, as well as its safety and tolerability. Renal PPAR-α was highly expressed in mesangial cells, proximal renal tubules, and collecting ducts [36,37]. In addition to the above-mentioned regulation of glucose and lipid metabolism, PPAR-α plays a role in regulating cell differentiation, cell cycle, extracellular matrix, and inflammatory pathways. A fenofibrate intervention and event lowering in diabetes (FIELD) study found that FIELD can significantly reduce the progression of albuminuria [15,16,17,37]. A subgroup analysis of the FIELD study found that fenofibrate reduced the deterioration of T2DM albuminuria by 24% compared to 11% with placebo. The subgroup analysis of the FIELD study found a 31 and 30% reduction in the number of cases of Fenofibrate DR requiring first laser treatment, respectively [36,37]. A subgroup analysis of patients who persisted to the end of follow-up, grading retinal status based on fluorescein fundus angiography results and using grade 2 progression in DR as the study endpoint, found that the risk of non-Nobel ennoblemen needing first laser therapy in this population was reduced by 70% [15,37,38]. However, the application of fenofibrate did not reduce the occurrence of DR, the progression of hard exudation, and the deterioration of vision, but the progression of the original retinopathy was significantly slow [38].

3.4.3 Statins

Simvastatin can correct the production of reactive oxygen species induced by Ang II, enhance the biological activity of nitric oxide, reduce the production of nitrosine, and slow down the occurrence of DKD [38,39]. The Diabetes Control Cardiovascular Risk Group reported that fenofibrate combined with simvastatin reduced the progression of DR In T2DM patients by 40% for 4 years, and this effect was independent of the effect of blood glucose [39,40].

3.4.4 Anti-VEGF

VEGF has a variety of biological functions, can increase vascular permeability, promote vascular endothelial cell migration, division, and proliferation, and thus promote angiogenesis [14,40]. Studies have shown that VEGF is closely related to the occurrence and development of diabetic microvascular complications. Intravitreal injection of anti-VEGF monoclonal antibody bevacizumab can effectively treat diabetic macular edema and can be used as an adjunctive therapy before advanced PDR surgery, greatly improving the surgical outcome [40,41].

3.4.5 Antioxidant

There are many such drugs, such as α-lipoic acid, triphenylphosphate-bound coenzyme Q (MitoQ), L-propionyl-carnitine, LY333531, PJ34 and FP15 [36,37,38,40,41]. Currently, alpha-lipoic acid is routinely used in the clinic. Alpha-lipoic acid and its reduced form dihydrolipoic acid are powerful antioxidants that work by scavenging oxygen free radicals, interacting with other antioxidants, and inhibiting lipid peroxidation [16,17,18,19,41]. α-Lipoic acid can inhibit the activation of nuclear factor κB induced by hydrogen peroxide, tumor necrosis factor α, and advanced glycosylated end products to protect the function of vascular endothelial cells, increase the blood flow of neurotrophic vessels, promote nerve myelin formation and axon regeneration, repair damaged nerves, improve nerve conduction speed, and improve neuropathy symptoms [15,16,17,39]. Animal experiments show that α-lipoic acid has a good antioxidant effect, which can reduce the damage of free radicals and improve nerve function [14,15,16,17]. The statement of American Diabetes Association guidelines on diabetic neuropathy considers alpha-lipoic acid to be effective in the treatment of diabetic neuropathy, and many large evidence-based medical studies have subsequently proved that alpha-lipoic acid has a better peripheral neuroprotective effect [39,40,41].

In recent years, some scholars have also discussed the use of α-lipoic acid in the treatment of DKD. Clinical studies have shown that diabetic patients who were given 600 mg alpha-lipoic acid daily with urinary microalbumin creatinine ratio (ACR) <200 mg/L showed no progress in ACR after 18 months [40,41,42]. ACR in the control group was significantly increased (P < 0.05). Animal studies have shown that the combination of RAS blockers irbesartan and alpha-lipoic acid can more effectively control the growth of glomerular volume, the thickening of the sac basement membrane, glomerular basement membrane, and tubular basement membrane, as well as the expansion of mesangial matrix and tubular expansion [42,43].

3.4.6 Others

PKC inhibitors, insulin sensitizers thiazolidinediones such as rosiglitazone, and peroxisome proliferation-activating receptor-δ (PPARδ) agonist GW501516 are also being studied to prevent the development of diabetic microvascular complications [43,44]. With the deepening of the understanding of the pathogenesis of diabetic microvascular, new methods for the treatment of diabetic microvascular complications are emerging [45]. However, there has been no breakthrough in the treatment of diabetic microvascular complications. Therefore, prevention of diabetic microvascular complications is more important than treatment [46].

4 Discussion

The incidence and disability rate of diabetes are becoming more and more serious with the intensification of diet structure and aging population. The occurrence of microvascular complications in diabetic patients has become an important killer that threatens their health and survival. DN, DPN, and DR are the most common and serious diabetic microvascular complications in clinical patients. Although the epidemiology, molecular mechanisms of occurrence and development, risk factors, and treatment of diabetic microvascular complications have been analyzed in this review, it should be noted that the occurrence of diabetes and its microvascular complications is not the result of a single signaling pathway. In future studies, different pathological models, in vivo and in vitro should be studied from multiple levels and perspectives, to provide reference for more accurately elucidating the pathogenesis and treatment of diabetic microvascular complications.

# Rui Xu and Ziming Fang contributed equally to this work.

Acknowledgments

All authors contributed to the study and agreed to be listed as authors.

  1. Funding information: This study did not receive any funding in any form.

  2. Author contributions: Rui Xu and Ziming Fang are responsible for writing the manuscript; Hongyu Wang and Boyang Zhang are responsible for collecting literature; Ye Gu and Liying Yu are responsible for creating images; Jingyu Xu is responsible for guiding the content of the article.

  3. Conflict of interest: The authors declare that they have no conflicts of interest.

  4. Data availability statement: The data could be obtained by contacting the corresponding author.

References

[1] Xiong J, Hu H, Guo R, Wang H, Jiang H. Mesenchymal stem cell exosomes as a new strategy for the treatment of diabetes complications. Front Endocrinol (Lausanne). 2021 Apr;12:646233.10.3389/fendo.2021.646233Search in Google Scholar PubMed PubMed Central

[2] Kaur P, Kotru S, Singh S, Munshi A. Role of miRNAs in diabetic neuropathy: Mechanisms and possible interventions. Mol Neurobiol. 2022 Mar;59(3):1836–49.10.1007/s12035-021-02662-wSearch in Google Scholar PubMed

[3] An T, Chen Y, Tu Y, Lin P. Mesenchymal stromal cell-derived extracellular vesicles in the treatment of diabetic foot ulcers: Application and challenges. Stem Cell Rev Rep. 2021 Apr;17(2):369–78.10.1007/s12015-020-10014-9Search in Google Scholar PubMed

[4] Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022 Aug;16(8):102581.10.1016/j.dsx.2022.102581Search in Google Scholar PubMed

[5] Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, et al. Diabetic foot infections: A comprehensive overview. Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):26–37.Search in Google Scholar

[6] Oost LJ, van der Heijden AAWA, Vermeulen EA. Serum magnesium is inversely associated with heart failure, atrial fibrillation, and microvascular complications in type 2 diabetes. Diabetes Care. 2021 Aug;44(8):1757–65.10.2337/dc21-0236Search in Google Scholar PubMed

[7] Liu G, Li Y, Pan A, Hu Y, Chen S, Qian F, et al. Adherence to a healthy lifestyle in association with microvascular complications among adults with type 2 diabetes. JAMA Netw Open. 2023 Jan;6(1):e2252239.10.1001/jamanetworkopen.2022.52239Search in Google Scholar PubMed PubMed Central

[8] Gazzaruso C, Montalcini T, Gallotti P, Ferrulli A, Massa Saluzzo C, Pujia A, et al. Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease. Endocrine. 2023 Apr;80(1):71–8.10.1007/s12020-022-03291-6Search in Google Scholar PubMed

[9] Burgess J, Frank B, Marshall A, Khalil RS, Ponirakis G, Petropoulos IN, et al. Early detection of diabetic peripheral neuropathy: A focus on small nerve fibres. Diagnostics (Basel). 2021 Jan;11(2):165.10.3390/diagnostics11020165Search in Google Scholar PubMed PubMed Central

[10] Ziegler D, Porta M, Papanas N, Mota M, Jermendy G, Beltramo E, et al. The role of biofactors in diabetic microvascular complications. Curr Diabetes Rev. 2022;18(4):e250821195830.10.2174/1871527320666210825112240Search in Google Scholar PubMed PubMed Central

[11] Chang LS, Jang DW, Kim YH, Kim SW. Diabetic foot resurfacing using microvascular tissue transfer from lateral thoracic region. Diabetes Metab Res Rev. 2023 Feb;39(2):e3593.10.1002/dmrr.3593Search in Google Scholar PubMed

[12] Joseph S, Munshi B, Agarini R, Kwok RCH, Green DJ, Jansen S. Near infrared spectroscopy in peripheral artery disease and the diabetic foot: A systematic review. Diabetes Metab Res Rev. 2022 Oct;38(7):e3571.10.1002/dmrr.3571Search in Google Scholar PubMed

[13] Bundó M, Vlacho B, Llussà J, Puig-Treserra R, Mata-Cases M, Cos X, et al. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018. Front Endocrinol (Lausanne). 2022 Oct;13:1024904.10.3389/fendo.2022.1024904Search in Google Scholar PubMed PubMed Central

[14] Rosi LM, Jones AS, Topliss DJ, Bach LA. Demographics and outcomes of inpatients with diabetic foot ulcers treated conservatively and surgically in a metropolitan hospital network. Diabetes Res Clin Pract. 2021 May;175:108821.10.1016/j.diabres.2021.108821Search in Google Scholar PubMed

[15] Sela Y, Grinberg K, Cukierman-Yaffe T. Relationship between cognitive function in individuals with diabetic foot ulcer and mortality. Diabetol Metab Syndr. 2022 Sep;14(1):133.10.1186/s13098-022-00901-1Search in Google Scholar PubMed PubMed Central

[16] Sharma S, Schaper N, Rayman G. Microangiopathy: Is it relevant to wound healing in diabetic foot disease? Diabetes Metab Res Rev. 2020 Mar;36(Suppl 1):e3244.10.1002/dmrr.3244Search in Google Scholar PubMed

[17] Kempegowda P, Sunsoa H, Chandan JS, Quinn LM, Amrelia PM, Atta SN. Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes. Ther Adv Endocrinol Metab. 2020 Oct;11:2042018820966428.10.1177/2042018820966428Search in Google Scholar PubMed PubMed Central

[18] Pandey S, Shamim A, Shaif M. Development and evaluation of Resveratrol-loaded liposomes in hydrogel-based wound dressing for diabetic foot ulcer. Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1811–25.10.1007/s00210-023-02441-5Search in Google Scholar PubMed

[19] Azmi S, Alam U, Burgess J, Malik RA. State-of-the-art pharmacotherapy for diabetic neuropathy. Expert Opin Pharmacother. 2021 Jan;22(1):55–68.10.1080/14656566.2020.1812578Search in Google Scholar PubMed

[20] Eleftheriadou I, Tentolouris A, Grigoropoulou P, Tsilingiris D, Anastasiou I, Kokkinos A, et al. The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus. J Diabetes Complications. 2019 Feb;33(2):165–70.10.1016/j.jdiacomp.2018.10.008Search in Google Scholar PubMed

[21] Afroz A, Zhang W, Wei Loh AJ, Jie Lee DX, Billah B. Macro- and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh. Diabetes Metab Syndr. 2019 Sep–Oct;13(5):2939–46.10.1016/j.dsx.2019.07.046Search in Google Scholar PubMed

[22] Azarova I, Klyosova E, Polonikov A. Single nucleotide polymorphisms of the RAC1 gene as novel susceptibility markers for neuropathy and microvascular complications in type 2 diabetes. Biomedicines. 2023 Mar;11(3):981.10.3390/biomedicines11030981Search in Google Scholar PubMed PubMed Central

[23] Gil CL, Hooker E, Larrivée B. Diabetic kidney disease, endothelial damage, and podocyte-endothelial crosstalk. Kidney Med. 2020 Dec;3(1):105–15.10.1016/j.xkme.2020.10.005Search in Google Scholar PubMed PubMed Central

[24] Finžgar M, Frangež HB, Cankar K, Frangež I. Transcutaneous application of the gaseous CO2 for improvement of the microvascular function in patients with diabetic foot ulcers. Microvasc Res. 2021 Jan;133:104100.10.1016/j.mvr.2020.104100Search in Google Scholar PubMed

[25] Li S, Nemeth I, Donnelly L, Hapca S, Zhou K. Visit-to-Visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2020 Feb;43(2):426–32.10.2337/dc19-0823Search in Google Scholar PubMed

[26] Alramadan MJ, Magliano DJ, Alhamrani HA, Alramadan AJ, Alameer SM, Amin GM, et al. Lifestyle factors and macro- and micro-vascular complications among people with type 2 diabetes in Saudi Arabia. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):484–91.10.1016/j.dsx.2018.11.007Search in Google Scholar PubMed

[27] Nkonge KM, Nkonge DK, Nkonge TN. Screening for diabetic peripheral neuropathy in resource-limited settings. Diabetol Metab Syndr. 2023 Mar;15(1):55.10.1186/s13098-023-01032-xSearch in Google Scholar PubMed PubMed Central

[28] Cui J, Zhang X, Guo C, Zhang L. The association of interieukin-6 polymorphism (rs1800795) with microvascular complications in type 2 diabetes mellitus. Biosci Rep. 2020 Oct;40(10):BSR20201105.10.1042/BSR20201105Search in Google Scholar PubMed PubMed Central

[29] Zochodne DW. The challenges of diabetic polyneuropathy: A brief update. Curr Opin Neurol. 2019 Oct;32(5):666–75.10.1097/WCO.0000000000000723Search in Google Scholar PubMed

[30] Lee AS, Twigg SM, Flack JR. Metabolic syndrome in type 1 diabetes and its association with diabetes complications. Diabet Med. 2021 Feb;38(2):e14376.10.1111/dme.14376Search in Google Scholar PubMed

[31] Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019 May-Jun;13(3):2300–12.10.1016/j.dsx.2019.05.018Search in Google Scholar PubMed

[32] Wang YP, Cheng RH, He Y, Mu LZ. Thermal analysis of blood flow alterations in human hand and foot based on vascular-porous media model. Front Bioeng Biotechnol. 2022 Jan;9:786615.10.3389/fbioe.2021.786615Search in Google Scholar PubMed PubMed Central

[33] Laxy M, Becker J, Kähm K, Holle R, Peters A, Thorand B, et al. Utility decrements associated with diabetes and related complications: Estimates from a population-based study in Germany. Value Health. 2021 Feb;24(2):274–80.10.1016/j.jval.2020.09.017Search in Google Scholar PubMed

[34] Fagher K, Löndahl M. The combined impact of ankle-brachial index and transcutaneous oxygen pressure on mortality in patients with type 2 diabetes and foot ulcers. Acta Diabetol. 2021 Oct;58(10):1359–65.10.1007/s00592-021-01731-9Search in Google Scholar PubMed PubMed Central

[35] Khalil SA, Megallaa MH, Rohoma KH, Guindy MA, Zaki A, Hassanein M, et al. Prevalence of chronic diabetic complications in newly diagnosed versus known type 2 diabetic subjects in a sample of Alexandria population, Egypt. Curr Diabetes Rev. 2019;15(1):74–83.10.2174/1573399814666180125100917Search in Google Scholar PubMed

[36] Raghav A, Tripathi P, Mishra BK, Jeong GB, Banday S, Gautam KA, et al. Mesenchymal stromal cell-derived tailored exosomes treat bacteria-associated diabetes foot ulcers: A customized approach from bench to bed. Front Microbiol. 2021 Jul;12:712588.10.3389/fmicb.2021.712588Search in Google Scholar PubMed PubMed Central

[37] Govindarajan Venguidesvarane A, Jasmine A, Varadarajan S. Prevalence of vascular complications among type 2 diabetic patients in a rural health center in South India. J Prim Care Community Health. 2020 Jan–Dec;11:2150132720959962.10.1177/2150132720959962Search in Google Scholar PubMed PubMed Central

[38] Ren W, Duan Y, Jan YK, Li J, Liu W, Pu F, et al. Effect of intermittent pneumatic compression with different inflation pressures on the distal microvascular responses of the foot in people with type 2 diabetes mellitus. Int Wound J. 2022 Aug;19(5):968–77.10.1111/iwj.13693Search in Google Scholar PubMed PubMed Central

[39] VatanIman R, Malekpour SH, Afshari A, Zare M. MiR-770-5p, miR-661 and miR-571 expression level in serum and tissue samples of foot ulcer caused by diabetes mellitus type II in Iranian population. Mol Biol Rep. 2021 Dec;48(12):7811–8.10.1007/s11033-021-06798-9Search in Google Scholar PubMed

[40] Singh P, Adderley N, Subramanian A, Gokhale K, Singhal R, Toulis KA, et al. The impact of bariatric surgery on incident microvascular complications in patients with type 2 diabetes: A matched controlled population-based retrospective cohort study. Diabetes Care. 2021 Jan;44(1):116–24.10.2337/dc20-0571Search in Google Scholar PubMed PubMed Central

[41] Yang X, Liu Q, Fan Y, Ding L, Wang R, Hu G, et al. Cardiovascular risk factor status in hospitalized patients with type 2 diabetes in China. Front Endocrinol (Lausanne). 2021 Jul;12:664183.10.3389/fendo.2021.664183Search in Google Scholar PubMed PubMed Central

[42] Patel S, Pangarkar A, Mahajan S, Majumdar A. Therapeutic potential of endoplasmic reticulum stress inhibitors in the treatment of diabetic peripheral neuropathy. Metab Brain Dis. 2023 Aug;38(6):1841–56.10.1007/s11011-023-01239-xSearch in Google Scholar PubMed

[43] Amour AA, Chamba N, Kayandabila J, Lyaruu IA, Marieke D, Shao ER, et al. Prevalence, patterns, and factors associated with peripheral neuropathies among diabetic patients at tertiary hospital in the Kilimanjaro region: Descriptive cross-sectional study from North-Eastern Tanzania. Int J Endocrinol. 2019 Jun;2019:5404781.10.1155/2019/5404781Search in Google Scholar PubMed PubMed Central

[44] Zhu X, Zhang Y, Liang F, Yin J, Jiang L, Cai W, et al. Relationship between plasma growth differentiation factor 15 levels and complications of type 2 diabetes mellitus: A cross-sectional study. Can J Diabetes. 2023 Mar;47(2):117–23.e7.10.1016/j.jcjd.2022.09.116Search in Google Scholar PubMed

[45] Adderley NJ, Subramanian A, Toulis K, Gokhale K, Taverner T, Hanif W, et al. Obstructive sleep apnea, a risk factor for cardiovascular and microvascular disease in patients with type 2 diabetes: findings from a population-based cohort study. Diabetes Care. 2020 Aug;43(8):1868–77.10.2337/dc19-2116Search in Google Scholar PubMed

[46] Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117–24.10.2174/1570161117666190502103733Search in Google Scholar PubMed

Received: 2023-09-12
Revised: 2023-12-23
Accepted: 2024-01-05
Published Online: 2024-04-17

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway
  3. STK11 (LKB1) mutation suppresses ferroptosis in lung adenocarcinoma by facilitating monounsaturated fatty acid synthesis
  4. Association of SOX6 gene polymorphisms with Kashin-Beck disease risk in the Chinese Han population
  5. The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma
  6. METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC
  7. Identification and validation of molecular subtypes and prognostic signature for stage I and stage II gastric cancer based on neutrophil extracellular traps
  8. Novel lumbar plexus block versus femoral nerve block for analgesia and motor recovery after total knee arthroplasty
  9. Correlation between ABCB1 and OLIG2 polymorphisms and the severity and prognosis of patients with cerebral infarction
  10. Study on the radiotherapy effect and serum neutral granulocyte lymphocyte ratio and inflammatory factor expression of nasopharyngeal carcinoma
  11. Transcriptome analysis of effects of Tecrl deficiency on cardiometabolic and calcium regulation in cardiac tissue
  12. Aflatoxin B1 induces infertility, fetal deformities, and potential therapies
  13. Serum levels of HMW adiponectin and its receptors are associated with cytokine levels and clinical characteristics in chronic obstructive pulmonary disease
  14. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
  15. Understand how machine learning impact lung cancer research from 2010 to 2021: A bibliometric analysis
  16. Pressure ulcers in German hospitals: Analysis of reimbursement and length of stay
  17. Metformin plus L-carnitine enhances brown/beige adipose tissue activity via Nrf2/HO-1 signaling to reduce lipid accumulation and inflammation in murine obesity
  18. Downregulation of carbonic anhydrase IX expression in mouse xenograft nasopharyngeal carcinoma model via doxorubicin nanobubble combined with ultrasound
  19. Feasibility of 3-dimensional printed models in simulated training and teaching of transcatheter aortic valve replacement
  20. miR-335-3p improves type II diabetes mellitus by IGF-1 regulating macrophage polarization
  21. The analyses of human MCPH1 DNA repair machinery and genetic variations
  22. Activation of Piezo1 increases the sensitivity of breast cancer to hyperthermia therapy
  23. Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma
  24. Changes of serum CA125 and PGE2 before and after high-intensity focused ultrasound combined with GnRH-a in treatment of patients with adenomyosis
  25. The clinical value of the hepatic venous pressure gradient in patients undergoing hepatic resection for hepatocellular carcinoma with or without liver cirrhosis
  26. Development and validation of a novel model to predict pulmonary embolism in cardiology suspected patients: A 10-year retrospective analysis
  27. Downregulation of lncRNA XLOC_032768 in diabetic patients predicts the occurrence of diabetic nephropathy
  28. Circ_0051428 targeting miR-885-3p/MMP2 axis enhances the malignancy of cervical cancer
  29. Effectiveness of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke
  30. The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci
  31. Evaluating the impact of childhood BMI on the risk of coronavirus disease 2019: A Mendelian randomization study
  32. Lactate dehydrogenase to albumin ratio is associated with in-hospital mortality in patients with acute heart failure: Data from the MIMIC-III database
  33. CD36-mediated podocyte lipotoxicity promotes foot process effacement
  34. Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis
  35. FLRT2 mediates chondrogenesis of nasal septal cartilage and mandibular condyle cartilage
  36. Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
  37. Let-7 family regulates HaCaT cell proliferation and apoptosis via the ΔNp63/PI3K/AKT pathway
  38. Phospholipid transfer protein ameliorates sepsis-induced cardiac dysfunction through NLRP3 inflammasome inhibition
  39. Postoperative cognitive dysfunction in elderly patients with colorectal cancer: A randomized controlled study comparing goal-directed and conventional fluid therapy
  40. Long-pulsed ultrasound-mediated microbubble thrombolysis in a rat model of microvascular obstruction
  41. High SEC61A1 expression predicts poor outcome of acute myeloid leukemia
  42. Comparison of polymerase chain reaction and next-generation sequencing with conventional urine culture for the diagnosis of urinary tract infections: A meta-analysis
  43. Secreted frizzled-related protein 5 protects against renal fibrosis by inhibiting Wnt/β-catenin pathway
  44. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis
  45. Overexpression of miR-532-5p restrains oxidative stress response of chondrocytes in nontraumatic osteonecrosis of the femoral head by inhibiting ABL1
  46. Autologous liver transplantation for unresectable hepatobiliary malignancies in enhanced recovery after surgery model
  47. Clinical analysis of incomplete rupture of the uterus secondary to previous cesarean section
  48. Abnormal sleep duration is associated with sarcopenia in older Chinese people: A large retrospective cross-sectional study
  49. No genetic causality between obesity and benign paroxysmal vertigo: A two-sample Mendelian randomization study
  50. Identification and validation of autophagy-related genes in SSc
  51. Long non-coding RNA SRA1 suppresses radiotherapy resistance in esophageal squamous cell carcinoma by modulating glycolytic reprogramming
  52. Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
  53. The possible role of oxidative stress marker glutathione in the assessment of cognitive impairment in multiple sclerosis
  54. Compilation of a self-management assessment scale for postoperative patients with aortic dissection
  55. Left atrial appendage closure in conjunction with radiofrequency ablation: Effects on left atrial functioning in patients with paroxysmal atrial fibrillation
  56. Effect of anterior femoral cortical notch grade on postoperative function and complications during TKA surgery: A multicenter, retrospective study
  57. Clinical characteristics and assessment of risk factors in patients with influenza A-induced severe pneumonia after the prevalence of SARS-CoV-2
  58. Analgesia nociception index is an indicator of laparoscopic trocar insertion-induced transient nociceptive stimuli
  59. High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression
  60. Factors influencing cardiovascular system-related post-COVID-19 sequelae: A single-center cohort study
  61. HOXD10 regulates intestinal permeability and inhibits inflammation of dextran sulfate sodium-induced ulcerative colitis through the inactivation of the Rho/ROCK/MMPs axis
  62. Mesenchymal stem cell-derived exosomal miR-26a induces ferroptosis, suppresses hepatic stellate cell activation, and ameliorates liver fibrosis by modulating SLC7A11
  63. Endovascular thrombectomy versus intravenous thrombolysis for primary distal, medium vessel occlusion in acute ischemic stroke
  64. ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis
  65. Prognostic value of EIF5A2 in solid tumors: A meta-analysis and bioinformatics analysis
  66. The role of enhanced expression of Cx43 in patients with ulcerative colitis
  67. Choosing a COVID-19 vaccination site might be driven by anxiety and body vigilance
  68. Role of ICAM-1 in triple-negative breast cancer
  69. Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2
  70. HLA-DRB5 promotes immune thrombocytopenia via activating CD8+ T cells
  71. Efficacy and factors of myofascial release therapy combined with electrical and magnetic stimulation in the treatment of chronic pelvic pain syndrome
  72. Efficacy of tacrolimus monotherapy in primary membranous nephropathy
  73. Mechanisms of Tripterygium wilfordii Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking
  74. FBXO45 levels regulated ferroptosis renal tubular epithelial cells in a model of diabetic nephropathy by PLK1
  75. Optimizing anesthesia strategies to NSCLC patients in VATS procedures: Insights from drug requirements and patient recovery patterns
  76. Alpha-lipoic acid upregulates the PPARγ/NRF2/GPX4 signal pathway to inhibit ferroptosis in the pathogenesis of unexplained recurrent pregnancy loss
  77. Correlation between fat-soluble vitamin levels and inflammatory factors in paediatric community-acquired pneumonia: A prospective study
  78. CD1d affects the proliferation, migration, and apoptosis of human papillary thyroid carcinoma TPC-1 cells via regulating MAPK/NF-κB signaling pathway
  79. miR-let-7a inhibits sympathetic nerve remodeling after myocardial infarction by downregulating the expression of nerve growth factor
  80. Immune response analysis of solid organ transplantation recipients inoculated with inactivated COVID-19 vaccine: A retrospective analysis
  81. The H2Valdien derivatives regulate the epithelial–mesenchymal transition of hepatoma carcinoma cells through the Hedgehog signaling pathway
  82. Clinical efficacy of dexamethasone combined with isoniazid in the treatment of tuberculous meningitis and its effect on peripheral blood T cell subsets
  83. Comparison of short-segment and long-segment fixation in treatment of degenerative scoliosis and analysis of factors associated with adjacent spondylolisthesis
  84. Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway
  85. Methylation regulation for FUNDC1 stability in childhood leukemia was up-regulated and facilitates metastasis and reduces ferroptosis of leukemia through mitochondrial damage by FBXL2
  86. Correlation of single-fiber electromyography studies and functional status in patients with amyotrophic lateral sclerosis
  87. Risk factors of postoperative airway obstruction complications in children with oral floor mass
  88. Expression levels and clinical significance of serum miR-19a/CCL20 in patients with acute cerebral infarction
  89. Physical activity and mental health trends in Korean adolescents: Analyzing the impact of the COVID-19 pandemic from 2018 to 2022
  90. Evaluating anemia in HIV-infected patients using chest CT
  91. Ponticulus posticus and skeletal malocclusion: A pilot study in a Southern Italian pre-orthodontic court
  92. Causal association of circulating immune cells and lymphoma: A Mendelian randomization study
  93. Assessment of the renal function and fibrosis indexes of conventional western medicine with Chinese medicine for dredging collaterals on treating renal fibrosis: A systematic review and meta-analysis
  94. Comprehensive landscape of integrator complex subunits and their association with prognosis and tumor microenvironment in gastric cancer
  95. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: A drug Mendelian randomization study
  96. Population pharmacokinetics of meropenem in critically ill patients
  97. Comparison of the ability of newly inflammatory markers to predict complicated appendicitis
  98. Comparative morphology of the cruciate ligaments: A radiological study
  99. Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator
  100. Serum SIRT3 levels in epilepsy patients and its association with clinical outcomes and severity: A prospective observational study
  101. SHP-1 mediates cigarette smoke extract-induced epithelial–mesenchymal transformation and inflammation in 16HBE cells
  102. Acute hyper-hypoxia accelerates the development of depression in mice via the IL-6/PGC1α/MFN2 signaling pathway
  103. The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma
  104. Physical fitness and blood parameters outcomes of breast cancer survivor in a low-intensity circuit resistance exercise program
  105. Exploring anesthetic-induced gene expression changes and immune cell dynamics in atrial tissue post-coronary artery bypass graft surgery
  106. Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism
  107. Analysis of the risk factors of the radiation-induced encephalopathy in nasopharyngeal carcinoma: A retrospective cohort study
  108. Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review
  109. Evaluation of upper airway ultrasonographic measurements in predicting difficult intubation: A cross-section of the Turkish population
  110. Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer
  111. Postural stability after operative reconstruction of the AFTL in chronic ankle instability comparing three different surgical techniques
  112. Research trends related to emergence agitation in the post-anaesthesia care unit from 2001 to 2023: A bibliometric analysis
  113. Frequency and clinicopathological correlation of gastrointestinal polyps: A six-year single center experience
  114. ACSL4 mediates inflammatory bowel disease and contributes to LPS-induced intestinal epithelial cell dysfunction by activating ferroptosis and inflammation
  115. Affibody-based molecular probe 99mTc-(HE)3ZHER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
  116. Effectiveness of nutritional support for clinical outcomes in gastric cancer patients: A meta-analysis of randomized controlled trials
  117. The relationship between IFN-γ, IL-10, IL-6 cytokines, and severity of the condition with serum zinc and Fe in children infected with Mycoplasma pneumoniae
  118. Paraquat disrupts the blood–brain barrier by increasing IL-6 expression and oxidative stress through the activation of PI3K/AKT signaling pathway
  119. Sleep quality associate with the increased prevalence of cognitive impairment in coronary artery disease patients: A retrospective case–control study
  120. Dioscin protects against chronic prostatitis through the TLR4/NF-κB pathway
  121. Association of polymorphisms in FBN1, MYH11, and TGF-β signaling-related genes with susceptibility of sporadic thoracic aortic aneurysm and dissection in the Zhejiang Han population
  122. Application value of multi-parameter magnetic resonance image-transrectal ultrasound cognitive fusion in prostate biopsy
  123. Laboratory variables‐based artificial neural network models for predicting fatty liver disease: A retrospective study
  124. Decreased BIRC5-206 promotes epithelial–mesenchymal transition in nasopharyngeal carcinoma through sponging miR-145-5p
  125. Sepsis induces the cardiomyocyte apoptosis and cardiac dysfunction through activation of YAP1/Serpine1/caspase-3 pathway
  126. Assessment of iron metabolism and iron deficiency in incident patients on incident continuous ambulatory peritoneal dialysis
  127. Tibial periosteum flap combined with autologous bone grafting in the treatment of Gustilo-IIIB/IIIC open tibial fractures
  128. The application of intravenous general anesthesia under nasopharyngeal airway assisted ventilation undergoing ureteroscopic holmium laser lithotripsy: A prospective, single-center, controlled trial
  129. Long intergenic noncoding RNA for IGF2BP2 stability suppresses gastric cancer cell apoptosis by inhibiting the maturation of microRNA-34a
  130. Role of FOXM1 and AURKB in regulating keratinocyte function in psoriasis
  131. Parental control attitudes over their pre-school children’s diet
  132. The role of auto-HSCT in extranodal natural killer/T cell lymphoma
  133. Significance of negative cervical cytology and positive HPV in the diagnosis of cervical lesions by colposcopy
  134. Echinacoside inhibits PASMCs calcium overload to prevent hypoxic pulmonary artery remodeling by regulating TRPC1/4/6 and calmodulin
  135. ADAR1 plays a protective role in proximal tubular cells under high glucose conditions by attenuating the PI3K/AKT/mTOR signaling pathway
  136. The risk of cancer among insulin glargine users in Lithuania: A retrospective population-based study
  137. The unusual location of primary hydatid cyst: A case series study
  138. Intraoperative changes in electrophysiological monitoring can be used to predict clinical outcomes in patients with spinal cavernous malformation
  139. Obesity and risk of placenta accreta spectrum: A meta-analysis
  140. Shikonin alleviates asthma phenotypes in mice via an airway epithelial STAT3-dependent mechanism
  141. NSUN6 and HTR7 disturbed the stability of carotid atherosclerotic plaques by regulating the immune responses of macrophages
  142. The effect of COVID-19 lockdown on admission rates in Maternity Hospital
  143. Temporal muscle thickness is not a prognostic predictor in patients with high-grade glioma, an experience at two centers in China
  144. Luteolin alleviates cerebral ischemia/reperfusion injury by regulating cell pyroptosis
  145. Therapeutic role of respiratory exercise in patients with tuberculous pleurisy
  146. Effects of CFTR-ENaC on spinal cord edema after spinal cord injury
  147. Irisin-regulated lncRNAs and their potential regulatory functions in chondrogenic differentiation of human mesenchymal stem cells
  148. DMD mutations in pediatric patients with phenotypes of Duchenne/Becker muscular dystrophy
  149. Combination of C-reactive protein and fibrinogen-to-albumin ratio as a novel predictor of all-cause mortality in heart failure patients
  150. Significant role and the underly mechanism of cullin-1 in chronic obstructive pulmonary disease
  151. Ferroptosis-related prognostic model of mantle cell lymphoma
  152. Observation of choking reaction and other related indexes in elderly painless fiberoptic bronchoscopy with transnasal high-flow humidification oxygen therapy
  153. A bibliometric analysis of Prader-Willi syndrome from 2002 to 2022
  154. The causal effects of childhood sunburn occasions on melanoma: A univariable and multivariable Mendelian randomization study
  155. Oxidative stress regulates glycogen synthase kinase-3 in lymphocytes of diabetes mellitus patients complicated with cerebral infarction
  156. Role of COX6C and NDUFB3 in septic shock and stroke
  157. Trends in disease burden of type 2 diabetes, stroke, and hypertensive heart disease attributable to high BMI in China: 1990–2019
  158. Purinergic P2X7 receptor mediates hyperoxia-induced injury in pulmonary microvascular endothelial cells via NLRP3-mediated pyroptotic pathway
  159. Investigating the role of oviductal mucosa–endometrial co-culture in modulating factors relevant to embryo implantation
  160. Analgesic effect of external oblique intercostal block in laparoscopic cholecystectomy: A retrospective study
  161. Elevated serum miR-142-5p correlates with ischemic lesions and both NSE and S100β in ischemic stroke patients
  162. Correlation between the mechanism of arteriopathy in IgA nephropathy and blood stasis syndrome: A cohort study
  163. Risk factors for progressive kyphosis after percutaneous kyphoplasty in osteoporotic vertebral compression fracture
  164. Predictive role of neuron-specific enolase and S100-β in early neurological deterioration and unfavorable prognosis in patients with ischemic stroke
  165. The potential risk factors of postoperative cognitive dysfunction for endovascular therapy in acute ischemic stroke with general anesthesia
  166. Fluoxetine inhibited RANKL-induced osteoclastic differentiation in vitro
  167. Detection of serum FOXM1 and IGF2 in patients with ARDS and their correlation with disease and prognosis
  168. Rhein promotes skin wound healing by activating the PI3K/AKT signaling pathway
  169. Differences in mortality risk by levels of physical activity among persons with disabilities in South Korea
  170. Review Articles
  171. Cutaneous signs of selected cardiovascular disorders: A narrative review
  172. XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis
  173. A narrative review on adverse drug reactions of COVID-19 treatments on the kidney
  174. Emerging role and function of SPDL1 in human health and diseases
  175. Adverse reactions of piperacillin: A literature review of case reports
  176. Molecular mechanism and intervention measures of microvascular complications in diabetes
  177. Regulation of mesenchymal stem cell differentiation by autophagy
  178. Molecular landscape of borderline ovarian tumours: A systematic review
  179. Advances in synthetic lethality modalities for glioblastoma multiforme
  180. Investigating hormesis, aging, and neurodegeneration: From bench to clinics
  181. Frankincense: A neuronutrient to approach Parkinson’s disease treatment
  182. Sox9: A potential regulator of cancer stem cells in osteosarcoma
  183. Early detection of cardiovascular risk markers through non-invasive ultrasound methodologies in periodontitis patients
  184. Advanced neuroimaging and criminal interrogation in lie detection
  185. Maternal factors for neural tube defects in offspring: An umbrella review
  186. The chemoprotective hormetic effects of rosmarinic acid
  187. CBD’s potential impact on Parkinson’s disease: An updated overview
  188. Progress in cytokine research for ARDS: A comprehensive review
  189. Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review
  190. NRXN1-related disorders, attempt to better define clinical assessment
  191. Lidocaine infusion for the treatment of complex regional pain syndrome: Case series and literature review
  192. Trends and future directions of autophagy in osteosarcoma: A bibliometric analysis
  193. Iron in ventricular remodeling and aneurysms post-myocardial infarction
  194. Case Reports
  195. Sirolimus potentiated angioedema: A case report and review of the literature
  196. Identification of mixed anaerobic infections after inguinal hernia repair based on metagenomic next-generation sequencing: A case report
  197. Successful treatment with bortezomib in combination with dexamethasone in a middle-aged male with idiopathic multicentric Castleman’s disease: A case report
  198. Complete heart block associated with hepatitis A infection in a female child with fatal outcome
  199. Elevation of D-dimer in eosinophilic gastrointestinal diseases in the absence of venous thrombosis: A case series and literature review
  200. Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with TFE3 gene fusion
  201. Advancing prenatal diagnosis: Echocardiographic detection of Scimitar syndrome in China – A case series
  202. Outcomes and complications of hemodialysis in patients with renal cancer following bilateral nephrectomy
  203. Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy
  204. Recurrent opportunistic infections in a HIV-negative patient with combined C6 and NFKB1 mutations: A case report, pedigree analysis, and literature review
  205. Letter to the Editor
  206. Letter to the Editor: Total parenteral nutrition-induced Wernicke’s encephalopathy after oncologic gastrointestinal surgery
  207. Erratum
  208. Erratum to “Bladder-embedded ectopic intrauterine device with calculus”
  209. Retraction
  210. Retraction of “XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis”
  211. Corrigendum
  212. Corrigendum to “Investigating hormesis, aging, and neurodegeneration: From bench to clinics”
  213. Corrigendum to “Frankincense: A neuronutrient to approach Parkinson’s disease treatment”
  214. Special Issue The evolving saga of RNAs from bench to bedside - Part II
  215. Machine-learning-based prediction of a diagnostic model using autophagy-related genes based on RNA sequencing for patients with papillary thyroid carcinoma
  216. Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening
  217. Elevated mRNA level indicates FSIP1 promotes EMT and gastric cancer progression by regulating fibroblasts in tumor microenvironment
  218. Special Issue Advancements in oncology: bridging clinical and experimental research - Part I
  219. Ultrasound-guided transperineal vs transrectal prostate biopsy: A meta-analysis of diagnostic accuracy and complication rates
  220. Assessment of diagnostic value of unilateral systematic biopsy combined with targeted biopsy in detecting clinically significant prostate cancer
  221. SENP7 inhibits glioblastoma metastasis and invasion by dissociating SUMO2/3 binding to specific target proteins
  222. MARK1 suppress malignant progression of hepatocellular carcinoma and improves sorafenib resistance through negatively regulating POTEE
  223. Analysis of postoperative complications in bladder cancer patients
  224. Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
  225. Special Issue Exploring the biological mechanism of human diseases based on MultiOmics Technology - Part I
  226. Comprehensive pan-cancer investigation of carnosine dipeptidase 1 and its prospective prognostic significance in hepatocellular carcinoma
  227. Identification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer
  228. Single-cell analysis identified key macrophage subpopulations associated with atherosclerosis
https://doi.org/10.1515/med-2023-0894
Keywords for this article
microvascular complication; epidemiology; molecular mechanism; risk factors; treatment
Creative Commons
BY 4.0

Articles in the same Issue

  1. Research Articles
  2. EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway
  3. STK11 (LKB1) mutation suppresses ferroptosis in lung adenocarcinoma by facilitating monounsaturated fatty acid synthesis
  4. Association of SOX6 gene polymorphisms with Kashin-Beck disease risk in the Chinese Han population
  5. The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma
  6. METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC
  7. Identification and validation of molecular subtypes and prognostic signature for stage I and stage II gastric cancer based on neutrophil extracellular traps
  8. Novel lumbar plexus block versus femoral nerve block for analgesia and motor recovery after total knee arthroplasty
  9. Correlation between ABCB1 and OLIG2 polymorphisms and the severity and prognosis of patients with cerebral infarction
  10. Study on the radiotherapy effect and serum neutral granulocyte lymphocyte ratio and inflammatory factor expression of nasopharyngeal carcinoma
  11. Transcriptome analysis of effects of Tecrl deficiency on cardiometabolic and calcium regulation in cardiac tissue
  12. Aflatoxin B1 induces infertility, fetal deformities, and potential therapies
  13. Serum levels of HMW adiponectin and its receptors are associated with cytokine levels and clinical characteristics in chronic obstructive pulmonary disease
  14. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
  15. Understand how machine learning impact lung cancer research from 2010 to 2021: A bibliometric analysis
  16. Pressure ulcers in German hospitals: Analysis of reimbursement and length of stay
  17. Metformin plus L-carnitine enhances brown/beige adipose tissue activity via Nrf2/HO-1 signaling to reduce lipid accumulation and inflammation in murine obesity
  18. Downregulation of carbonic anhydrase IX expression in mouse xenograft nasopharyngeal carcinoma model via doxorubicin nanobubble combined with ultrasound
  19. Feasibility of 3-dimensional printed models in simulated training and teaching of transcatheter aortic valve replacement
  20. miR-335-3p improves type II diabetes mellitus by IGF-1 regulating macrophage polarization
  21. The analyses of human MCPH1 DNA repair machinery and genetic variations
  22. Activation of Piezo1 increases the sensitivity of breast cancer to hyperthermia therapy
  23. Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma
  24. Changes of serum CA125 and PGE2 before and after high-intensity focused ultrasound combined with GnRH-a in treatment of patients with adenomyosis
  25. The clinical value of the hepatic venous pressure gradient in patients undergoing hepatic resection for hepatocellular carcinoma with or without liver cirrhosis
  26. Development and validation of a novel model to predict pulmonary embolism in cardiology suspected patients: A 10-year retrospective analysis
  27. Downregulation of lncRNA XLOC_032768 in diabetic patients predicts the occurrence of diabetic nephropathy
  28. Circ_0051428 targeting miR-885-3p/MMP2 axis enhances the malignancy of cervical cancer
  29. Effectiveness of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke
  30. The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci
  31. Evaluating the impact of childhood BMI on the risk of coronavirus disease 2019: A Mendelian randomization study
  32. Lactate dehydrogenase to albumin ratio is associated with in-hospital mortality in patients with acute heart failure: Data from the MIMIC-III database
  33. CD36-mediated podocyte lipotoxicity promotes foot process effacement
  34. Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis
  35. FLRT2 mediates chondrogenesis of nasal septal cartilage and mandibular condyle cartilage
  36. Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
  37. Let-7 family regulates HaCaT cell proliferation and apoptosis via the ΔNp63/PI3K/AKT pathway
  38. Phospholipid transfer protein ameliorates sepsis-induced cardiac dysfunction through NLRP3 inflammasome inhibition
  39. Postoperative cognitive dysfunction in elderly patients with colorectal cancer: A randomized controlled study comparing goal-directed and conventional fluid therapy
  40. Long-pulsed ultrasound-mediated microbubble thrombolysis in a rat model of microvascular obstruction
  41. High SEC61A1 expression predicts poor outcome of acute myeloid leukemia
  42. Comparison of polymerase chain reaction and next-generation sequencing with conventional urine culture for the diagnosis of urinary tract infections: A meta-analysis
  43. Secreted frizzled-related protein 5 protects against renal fibrosis by inhibiting Wnt/β-catenin pathway
  44. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis
  45. Overexpression of miR-532-5p restrains oxidative stress response of chondrocytes in nontraumatic osteonecrosis of the femoral head by inhibiting ABL1
  46. Autologous liver transplantation for unresectable hepatobiliary malignancies in enhanced recovery after surgery model
  47. Clinical analysis of incomplete rupture of the uterus secondary to previous cesarean section
  48. Abnormal sleep duration is associated with sarcopenia in older Chinese people: A large retrospective cross-sectional study
  49. No genetic causality between obesity and benign paroxysmal vertigo: A two-sample Mendelian randomization study
  50. Identification and validation of autophagy-related genes in SSc
  51. Long non-coding RNA SRA1 suppresses radiotherapy resistance in esophageal squamous cell carcinoma by modulating glycolytic reprogramming
  52. Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
  53. The possible role of oxidative stress marker glutathione in the assessment of cognitive impairment in multiple sclerosis
  54. Compilation of a self-management assessment scale for postoperative patients with aortic dissection
  55. Left atrial appendage closure in conjunction with radiofrequency ablation: Effects on left atrial functioning in patients with paroxysmal atrial fibrillation
  56. Effect of anterior femoral cortical notch grade on postoperative function and complications during TKA surgery: A multicenter, retrospective study
  57. Clinical characteristics and assessment of risk factors in patients with influenza A-induced severe pneumonia after the prevalence of SARS-CoV-2
  58. Analgesia nociception index is an indicator of laparoscopic trocar insertion-induced transient nociceptive stimuli
  59. High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression
  60. Factors influencing cardiovascular system-related post-COVID-19 sequelae: A single-center cohort study
  61. HOXD10 regulates intestinal permeability and inhibits inflammation of dextran sulfate sodium-induced ulcerative colitis through the inactivation of the Rho/ROCK/MMPs axis
  62. Mesenchymal stem cell-derived exosomal miR-26a induces ferroptosis, suppresses hepatic stellate cell activation, and ameliorates liver fibrosis by modulating SLC7A11
  63. Endovascular thrombectomy versus intravenous thrombolysis for primary distal, medium vessel occlusion in acute ischemic stroke
  64. ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis
  65. Prognostic value of EIF5A2 in solid tumors: A meta-analysis and bioinformatics analysis
  66. The role of enhanced expression of Cx43 in patients with ulcerative colitis
  67. Choosing a COVID-19 vaccination site might be driven by anxiety and body vigilance
  68. Role of ICAM-1 in triple-negative breast cancer
  69. Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2
  70. HLA-DRB5 promotes immune thrombocytopenia via activating CD8+ T cells
  71. Efficacy and factors of myofascial release therapy combined with electrical and magnetic stimulation in the treatment of chronic pelvic pain syndrome
  72. Efficacy of tacrolimus monotherapy in primary membranous nephropathy
  73. Mechanisms of Tripterygium wilfordii Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking
  74. FBXO45 levels regulated ferroptosis renal tubular epithelial cells in a model of diabetic nephropathy by PLK1
  75. Optimizing anesthesia strategies to NSCLC patients in VATS procedures: Insights from drug requirements and patient recovery patterns
  76. Alpha-lipoic acid upregulates the PPARγ/NRF2/GPX4 signal pathway to inhibit ferroptosis in the pathogenesis of unexplained recurrent pregnancy loss
  77. Correlation between fat-soluble vitamin levels and inflammatory factors in paediatric community-acquired pneumonia: A prospective study
  78. CD1d affects the proliferation, migration, and apoptosis of human papillary thyroid carcinoma TPC-1 cells via regulating MAPK/NF-κB signaling pathway
  79. miR-let-7a inhibits sympathetic nerve remodeling after myocardial infarction by downregulating the expression of nerve growth factor
  80. Immune response analysis of solid organ transplantation recipients inoculated with inactivated COVID-19 vaccine: A retrospective analysis
  81. The H2Valdien derivatives regulate the epithelial–mesenchymal transition of hepatoma carcinoma cells through the Hedgehog signaling pathway
  82. Clinical efficacy of dexamethasone combined with isoniazid in the treatment of tuberculous meningitis and its effect on peripheral blood T cell subsets
  83. Comparison of short-segment and long-segment fixation in treatment of degenerative scoliosis and analysis of factors associated with adjacent spondylolisthesis
  84. Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway
  85. Methylation regulation for FUNDC1 stability in childhood leukemia was up-regulated and facilitates metastasis and reduces ferroptosis of leukemia through mitochondrial damage by FBXL2
  86. Correlation of single-fiber electromyography studies and functional status in patients with amyotrophic lateral sclerosis
  87. Risk factors of postoperative airway obstruction complications in children with oral floor mass
  88. Expression levels and clinical significance of serum miR-19a/CCL20 in patients with acute cerebral infarction
  89. Physical activity and mental health trends in Korean adolescents: Analyzing the impact of the COVID-19 pandemic from 2018 to 2022
  90. Evaluating anemia in HIV-infected patients using chest CT
  91. Ponticulus posticus and skeletal malocclusion: A pilot study in a Southern Italian pre-orthodontic court
  92. Causal association of circulating immune cells and lymphoma: A Mendelian randomization study
  93. Assessment of the renal function and fibrosis indexes of conventional western medicine with Chinese medicine for dredging collaterals on treating renal fibrosis: A systematic review and meta-analysis
  94. Comprehensive landscape of integrator complex subunits and their association with prognosis and tumor microenvironment in gastric cancer
  95. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: A drug Mendelian randomization study
  96. Population pharmacokinetics of meropenem in critically ill patients
  97. Comparison of the ability of newly inflammatory markers to predict complicated appendicitis
  98. Comparative morphology of the cruciate ligaments: A radiological study
  99. Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator
  100. Serum SIRT3 levels in epilepsy patients and its association with clinical outcomes and severity: A prospective observational study
  101. SHP-1 mediates cigarette smoke extract-induced epithelial–mesenchymal transformation and inflammation in 16HBE cells
  102. Acute hyper-hypoxia accelerates the development of depression in mice via the IL-6/PGC1α/MFN2 signaling pathway
  103. The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma
  104. Physical fitness and blood parameters outcomes of breast cancer survivor in a low-intensity circuit resistance exercise program
  105. Exploring anesthetic-induced gene expression changes and immune cell dynamics in atrial tissue post-coronary artery bypass graft surgery
  106. Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism
  107. Analysis of the risk factors of the radiation-induced encephalopathy in nasopharyngeal carcinoma: A retrospective cohort study
  108. Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review
  109. Evaluation of upper airway ultrasonographic measurements in predicting difficult intubation: A cross-section of the Turkish population
  110. Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer
  111. Postural stability after operative reconstruction of the AFTL in chronic ankle instability comparing three different surgical techniques
  112. Research trends related to emergence agitation in the post-anaesthesia care unit from 2001 to 2023: A bibliometric analysis
  113. Frequency and clinicopathological correlation of gastrointestinal polyps: A six-year single center experience
  114. ACSL4 mediates inflammatory bowel disease and contributes to LPS-induced intestinal epithelial cell dysfunction by activating ferroptosis and inflammation
  115. Affibody-based molecular probe 99mTc-(HE)3ZHER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
  116. Effectiveness of nutritional support for clinical outcomes in gastric cancer patients: A meta-analysis of randomized controlled trials
  117. The relationship between IFN-γ, IL-10, IL-6 cytokines, and severity of the condition with serum zinc and Fe in children infected with Mycoplasma pneumoniae
  118. Paraquat disrupts the blood–brain barrier by increasing IL-6 expression and oxidative stress through the activation of PI3K/AKT signaling pathway
  119. Sleep quality associate with the increased prevalence of cognitive impairment in coronary artery disease patients: A retrospective case–control study
  120. Dioscin protects against chronic prostatitis through the TLR4/NF-κB pathway
  121. Association of polymorphisms in FBN1, MYH11, and TGF-β signaling-related genes with susceptibility of sporadic thoracic aortic aneurysm and dissection in the Zhejiang Han population
  122. Application value of multi-parameter magnetic resonance image-transrectal ultrasound cognitive fusion in prostate biopsy
  123. Laboratory variables‐based artificial neural network models for predicting fatty liver disease: A retrospective study
  124. Decreased BIRC5-206 promotes epithelial–mesenchymal transition in nasopharyngeal carcinoma through sponging miR-145-5p
  125. Sepsis induces the cardiomyocyte apoptosis and cardiac dysfunction through activation of YAP1/Serpine1/caspase-3 pathway
  126. Assessment of iron metabolism and iron deficiency in incident patients on incident continuous ambulatory peritoneal dialysis
  127. Tibial periosteum flap combined with autologous bone grafting in the treatment of Gustilo-IIIB/IIIC open tibial fractures
  128. The application of intravenous general anesthesia under nasopharyngeal airway assisted ventilation undergoing ureteroscopic holmium laser lithotripsy: A prospective, single-center, controlled trial
  129. Long intergenic noncoding RNA for IGF2BP2 stability suppresses gastric cancer cell apoptosis by inhibiting the maturation of microRNA-34a
  130. Role of FOXM1 and AURKB in regulating keratinocyte function in psoriasis
  131. Parental control attitudes over their pre-school children’s diet
  132. The role of auto-HSCT in extranodal natural killer/T cell lymphoma
  133. Significance of negative cervical cytology and positive HPV in the diagnosis of cervical lesions by colposcopy
  134. Echinacoside inhibits PASMCs calcium overload to prevent hypoxic pulmonary artery remodeling by regulating TRPC1/4/6 and calmodulin
  135. ADAR1 plays a protective role in proximal tubular cells under high glucose conditions by attenuating the PI3K/AKT/mTOR signaling pathway
  136. The risk of cancer among insulin glargine users in Lithuania: A retrospective population-based study
  137. The unusual location of primary hydatid cyst: A case series study
  138. Intraoperative changes in electrophysiological monitoring can be used to predict clinical outcomes in patients with spinal cavernous malformation
  139. Obesity and risk of placenta accreta spectrum: A meta-analysis
  140. Shikonin alleviates asthma phenotypes in mice via an airway epithelial STAT3-dependent mechanism
  141. NSUN6 and HTR7 disturbed the stability of carotid atherosclerotic plaques by regulating the immune responses of macrophages
  142. The effect of COVID-19 lockdown on admission rates in Maternity Hospital
  143. Temporal muscle thickness is not a prognostic predictor in patients with high-grade glioma, an experience at two centers in China
  144. Luteolin alleviates cerebral ischemia/reperfusion injury by regulating cell pyroptosis
  145. Therapeutic role of respiratory exercise in patients with tuberculous pleurisy
  146. Effects of CFTR-ENaC on spinal cord edema after spinal cord injury
  147. Irisin-regulated lncRNAs and their potential regulatory functions in chondrogenic differentiation of human mesenchymal stem cells
  148. DMD mutations in pediatric patients with phenotypes of Duchenne/Becker muscular dystrophy
  149. Combination of C-reactive protein and fibrinogen-to-albumin ratio as a novel predictor of all-cause mortality in heart failure patients
  150. Significant role and the underly mechanism of cullin-1 in chronic obstructive pulmonary disease
  151. Ferroptosis-related prognostic model of mantle cell lymphoma
  152. Observation of choking reaction and other related indexes in elderly painless fiberoptic bronchoscopy with transnasal high-flow humidification oxygen therapy
  153. A bibliometric analysis of Prader-Willi syndrome from 2002 to 2022
  154. The causal effects of childhood sunburn occasions on melanoma: A univariable and multivariable Mendelian randomization study
  155. Oxidative stress regulates glycogen synthase kinase-3 in lymphocytes of diabetes mellitus patients complicated with cerebral infarction
  156. Role of COX6C and NDUFB3 in septic shock and stroke
  157. Trends in disease burden of type 2 diabetes, stroke, and hypertensive heart disease attributable to high BMI in China: 1990–2019
  158. Purinergic P2X7 receptor mediates hyperoxia-induced injury in pulmonary microvascular endothelial cells via NLRP3-mediated pyroptotic pathway
  159. Investigating the role of oviductal mucosa–endometrial co-culture in modulating factors relevant to embryo implantation
  160. Analgesic effect of external oblique intercostal block in laparoscopic cholecystectomy: A retrospective study
  161. Elevated serum miR-142-5p correlates with ischemic lesions and both NSE and S100β in ischemic stroke patients
  162. Correlation between the mechanism of arteriopathy in IgA nephropathy and blood stasis syndrome: A cohort study
  163. Risk factors for progressive kyphosis after percutaneous kyphoplasty in osteoporotic vertebral compression fracture
  164. Predictive role of neuron-specific enolase and S100-β in early neurological deterioration and unfavorable prognosis in patients with ischemic stroke
  165. The potential risk factors of postoperative cognitive dysfunction for endovascular therapy in acute ischemic stroke with general anesthesia
  166. Fluoxetine inhibited RANKL-induced osteoclastic differentiation in vitro
  167. Detection of serum FOXM1 and IGF2 in patients with ARDS and their correlation with disease and prognosis
  168. Rhein promotes skin wound healing by activating the PI3K/AKT signaling pathway
  169. Differences in mortality risk by levels of physical activity among persons with disabilities in South Korea
  170. Review Articles
  171. Cutaneous signs of selected cardiovascular disorders: A narrative review
  172. XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis
  173. A narrative review on adverse drug reactions of COVID-19 treatments on the kidney
  174. Emerging role and function of SPDL1 in human health and diseases
  175. Adverse reactions of piperacillin: A literature review of case reports
  176. Molecular mechanism and intervention measures of microvascular complications in diabetes
  177. Regulation of mesenchymal stem cell differentiation by autophagy
  178. Molecular landscape of borderline ovarian tumours: A systematic review
  179. Advances in synthetic lethality modalities for glioblastoma multiforme
  180. Investigating hormesis, aging, and neurodegeneration: From bench to clinics
  181. Frankincense: A neuronutrient to approach Parkinson’s disease treatment
  182. Sox9: A potential regulator of cancer stem cells in osteosarcoma
  183. Early detection of cardiovascular risk markers through non-invasive ultrasound methodologies in periodontitis patients
  184. Advanced neuroimaging and criminal interrogation in lie detection
  185. Maternal factors for neural tube defects in offspring: An umbrella review
  186. The chemoprotective hormetic effects of rosmarinic acid
  187. CBD’s potential impact on Parkinson’s disease: An updated overview
  188. Progress in cytokine research for ARDS: A comprehensive review
  189. Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review
  190. NRXN1-related disorders, attempt to better define clinical assessment
  191. Lidocaine infusion for the treatment of complex regional pain syndrome: Case series and literature review
  192. Trends and future directions of autophagy in osteosarcoma: A bibliometric analysis
  193. Iron in ventricular remodeling and aneurysms post-myocardial infarction
  194. Case Reports
  195. Sirolimus potentiated angioedema: A case report and review of the literature
  196. Identification of mixed anaerobic infections after inguinal hernia repair based on metagenomic next-generation sequencing: A case report
  197. Successful treatment with bortezomib in combination with dexamethasone in a middle-aged male with idiopathic multicentric Castleman’s disease: A case report
  198. Complete heart block associated with hepatitis A infection in a female child with fatal outcome
  199. Elevation of D-dimer in eosinophilic gastrointestinal diseases in the absence of venous thrombosis: A case series and literature review
  200. Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with TFE3 gene fusion
  201. Advancing prenatal diagnosis: Echocardiographic detection of Scimitar syndrome in China – A case series
  202. Outcomes and complications of hemodialysis in patients with renal cancer following bilateral nephrectomy
  203. Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy
  204. Recurrent opportunistic infections in a HIV-negative patient with combined C6 and NFKB1 mutations: A case report, pedigree analysis, and literature review
  205. Letter to the Editor
  206. Letter to the Editor: Total parenteral nutrition-induced Wernicke’s encephalopathy after oncologic gastrointestinal surgery
  207. Erratum
  208. Erratum to “Bladder-embedded ectopic intrauterine device with calculus”
  209. Retraction
  210. Retraction of “XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis”
  211. Corrigendum
  212. Corrigendum to “Investigating hormesis, aging, and neurodegeneration: From bench to clinics”
  213. Corrigendum to “Frankincense: A neuronutrient to approach Parkinson’s disease treatment”
  214. Special Issue The evolving saga of RNAs from bench to bedside - Part II
  215. Machine-learning-based prediction of a diagnostic model using autophagy-related genes based on RNA sequencing for patients with papillary thyroid carcinoma
  216. Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening
  217. Elevated mRNA level indicates FSIP1 promotes EMT and gastric cancer progression by regulating fibroblasts in tumor microenvironment
  218. Special Issue Advancements in oncology: bridging clinical and experimental research - Part I
  219. Ultrasound-guided transperineal vs transrectal prostate biopsy: A meta-analysis of diagnostic accuracy and complication rates
  220. Assessment of diagnostic value of unilateral systematic biopsy combined with targeted biopsy in detecting clinically significant prostate cancer
  221. SENP7 inhibits glioblastoma metastasis and invasion by dissociating SUMO2/3 binding to specific target proteins
  222. MARK1 suppress malignant progression of hepatocellular carcinoma and improves sorafenib resistance through negatively regulating POTEE
  223. Analysis of postoperative complications in bladder cancer patients
  224. Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
  225. Special Issue Exploring the biological mechanism of human diseases based on MultiOmics Technology - Part I
  226. Comprehensive pan-cancer investigation of carnosine dipeptidase 1 and its prospective prognostic significance in hepatocellular carcinoma
  227. Identification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer
  228. Single-cell analysis identified key macrophage subpopulations associated with atherosclerosis
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 25.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0894/html
Scroll to top button